uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipel... uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Show more
~ Type B meeting scheduled with the FDA in the fourth quarter of 2024 to initiate discussions regarding a potential expedited clinical development pathway for AMT-130 in Huntington’s disease ~ ~...
LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.72 | 31.5596330275 | 5.45 | 7.96 | 5.35 | 1020243 | 7.28783362 | CS |
4 | 1.53 | 27.1276595745 | 5.64 | 7.96 | 5.35 | 740458 | 6.6500069 | CS |
12 | 0.59 | 8.96656534954 | 6.58 | 7.96 | 4.45 | 658636 | 5.96179016 | CS |
26 | 2.24 | 45.4361054767 | 4.93 | 11.35 | 3.73 | 1767513 | 7.69065319 | CS |
52 | 1.16 | 19.3011647255 | 6.01 | 11.35 | 3.73 | 1395897 | 7.07138691 | CS |
156 | -25.85 | -78.285887341 | 33.02 | 33.03 | 3.73 | 960334 | 11.83114873 | CS |
260 | -46.62 | -86.6703848299 | 53.79 | 76.6869 | 3.73 | 768663 | 20.05929658 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales